Last update: 23 January 2023
2021 vs. 2020
€/ mln
2021
2020
YoY
Sales
82.5
64.1
28.7%
Gross margin
27.8
20.3
7.5
Gross margin
33.6%
31.7%
1.9%
Selling and distribution as percentage of sales
-24.7%
-23.8%
-0.9%
Administrative costs as percentage of sales
-5.6%
-7.0%
1.4%
Other operating expensese as percetage of sales
-0.1%
0.0%
-0.1%
Adj. EBITDA*
2.7
0.6
2.1
Adj. EBITDA margin
3.3%
0.9%
2.3%
EBIT
0.3
(0.8)
1.1
Net result
(0.1)
(1.0)
0.9
*Adjusted to take into account the one-off costs related to the acquisition of AmicaFarmacia and the potential other M&A transactions costs